Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

RXRα is crucial for proper immune response and links diet to immune function.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Vitamin D and glucocorticoids affect bone growth, metabolism, and immune response.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Enhancing immune response can improve cancer treatment effectiveness.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Immune cells are crucial for hair growth and preventing hair loss.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

A specific DNA region controls skin cell gene expression by working with certain proteins.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Extracellular nucleic acids help start inflammation needed for tissue repair, but must be properly regulated.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.